BPC-157, TB-500, and Wolverine blend
iThriveMD names these compounds and blend in recovery-oriented protocols; the directory does not adopt the provider's repair or outcome claims.
Provider source ↗Encinitas, CA · Telehealth available
Provider overview
iThriveMD identifies Samir Damani, MD, as founder and publishes nine physical California clinic addresses plus a Scottsdale telehealth option. Its peptide page says peptide services are currently available at the Encinitas and Mission Valley clinics. The named compounds and programs below are provider-advertised offerings; the listing does not establish regulatory status, availability at every location, safety, effectiveness, or individual eligibility.
At a glance
503A and 503B labels describe statutory compounding pathways or public relationships. They do not mean a compounded drug is FDA-approved or that FDA endorses a facility.
Service catalog
Provider-advertised services, grouped for quick scanning with all details visible.
iThriveMD names these compounds and blend in recovery-oriented protocols; the directory does not adopt the provider's repair or outcome claims.
Provider source ↗The clinic lists GHK-Cu and a blend containing GHK-Cu, BPC-157, and TB-500; inclusion does not establish approval, safety, or effectiveness.
Provider source ↗These nasal peptide offerings appear in the clinic's cognitive-optimization catalog and remain subject to medical evaluation.
Provider source ↗PT-141 is listed as a clinician-prescribed sexual-wellness offering in the current peptide catalog.
Provider source ↗The clinic names these compounds in its performance and longevity pathway; the listing makes no regulatory or clinical endorsement.
Provider source ↗Thymosin Alpha-1 appears in the provider's peptide catalog as an immune-health pathway subject to provider assessment.
Provider source ↗The clinic advertises clinician-reviewed compounded semaglutide with diagnostic review and ongoing monitoring.
Provider source ↗The clinic advertises a compounded tirzepatide pathway with clinical intake and follow-up; patient eligibility is not implied.
Provider source ↗Laboratory-guided testosterone and enclomiphene pathways are listed for provider-diagnosed men's hormone concerns.
Provider source ↗The clinic advertises individualized perimenopause and menopause hormone evaluation and treatment planning.
Provider source ↗NAD+ injections and wafers are included in the current longevity catalog; the directory does not repeat the provider's outcome claims.
Provider source ↗The clinic publishes a broad biomarker panel with in-clinic or virtual provider review and ongoing tracking.
Provider source ↗Coverage and research
Review every state page this provider advertises serving, then use the related guides to evaluate services and claims.
Continue comparing
Evidence
Logo reproduced from the provider’s official website for identification. Logo source ↗
These links support the public facts recorded here. Provider-published information is not an independent endorsement.
Supports: identity founder and care team · Checked Jul 24, 2026
Supports: locations phone telehealth and entity disclosures · Checked Jul 24, 2026
Supports: peptide catalog availability and care process · Checked Jul 24, 2026
Supports: semaglutide program · Checked Jul 24, 2026
Supports: tirzepatide program · Checked Jul 24, 2026
Supports: hormone programs · Checked Jul 24, 2026
Supports: laboratory services · Checked Jul 24, 2026